Asset reviews
An asset review is a look back on a drug's whole life, written once the drug is approved, has failed or has been withdrawn. It asks what the science, the manufacturing and the market each contributed to the outcome.
Reviews
No asset reviews yet. An asset review is a look-back on a drug's whole life once it is approved, failed or withdrawn (§ Asset review).